4/A: DHI Group CFO Raime Leeby Muhle Receives 140,000 Shares of Restricted Stock

Sentiment:

SEC Form 4/A


Raime Leeby Muhle, CFO of DHI Group, Inc., was granted 140,000 shares of restricted stock on December 4, 2023, vesting over three years.

Summary

  • This Form 4/A filing reports a change in beneficial ownership for Raime Leeby Muhle, the Chief Financial Officer of DHI Group, Inc.
  • On December 4, 2023, Muhle was granted 140,000 shares of DHI Group common stock.
  • These shares are restricted stock and will vest in three equal installments on December 4, 2024, December 4, 2025, and December 4, 2026, contingent upon continuous service with the company.
  • This filing amends a previous Form 4 filed on October 27, 2023, to correct the transaction date and vesting schedule.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice that aligns management interests with shareholder value.

Positives

  • The grant of restricted stock aligns the CFO's interests with the long-term performance of DHI Group.
  • The vesting schedule incentivizes continued service and commitment from the CFO.

Risks

  • If the CFO leaves DHI Group before the vesting dates, unvested shares will be forfeited.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the restricted stock.

Industry Context

Granting restricted stock is a common practice in the industry to incentivize and retain key executives.

Stakeholder Impact

  • Shareholders may view the grant of restricted stock as a positive incentive for the CFO to drive long-term value.
  • Employees may see this as a positive sign of investment in leadership.

Key Dates

DateDescription
10/25/2023Issuer's board of directors approved an award of restricted stock to the reporting person.
10/27/2023Original Form 4 filed.
12/04/2023Date of earliest transaction and transaction date; grant of restricted stock.
12/04/2024First vesting date for 1/3 of the restricted stock.
12/04/2025Second vesting date for 1/3 of the restricted stock.
12/04/2026Final vesting date for 1/3 of the restricted stock.
03/08/2024Date of signature for the amended filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.